4//SEC Filing
Trainer John 4
Accession 0001209191-21-046170
CIK 0001538210other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:19 PM ET
Size
6.9 KB
Accession
0001209191-21-046170
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Trainer John
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-07-08$5.17/sh+3,432$17,743→ 61,770 total - Exercise/Conversion
Stock Option (right to buy)
2021-07-08−3,432→ 102,949 totalExercise: $5.17Exp: 2030-03-04→ Common Stock (3,432 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the shares on January 8, 2021 with the remainder vesting in equal installments every month thereafter, beginning on January 8, 2021 and ending on January 8, 2024.
Documents
Issuer
NexImmune, Inc.
CIK 0001538210
Entity typeother
Related Parties
1- filerCIK 0001843820
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 4:19 PM ET
- Size
- 6.9 KB